Section A: Cardiovascular System Indicator: Overweight/Obesity | 1 = Strongly Agree, 5 = Strongly Disagree |  | ||||
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | Comments | |
Lifestyle interventions should always be part of the first line approach to reducing BMI in overweight/obese* individuals with SMI (*WHO defines overweight as BMI ≥ 25 kg/m2 and obesity as BMI ≥ 30 kg/m2) |  |  |  |  |  |  |
Lifestyle interventions should be continued alongside additional interventions to reduce BMI in overweight /obese individuals with SMI | Â | Â | Â | Â | Â | Â |
Consider adjunctive metformin, unless contraindicated, in people with SMI who are prescribed clozapine or olanzapine and who have demonstrated early weight gain* *early weight gain is defined as 5% of body weight in the first month of treatment and is a predictor of long-term weight gain (> 15% over 3 months) |  |  |  |  |  |  |